286 related articles for article (PubMed ID: 25225064)
1. Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.
Nickerson ML; Dancik GM; Im KM; Edwards MG; Turan S; Brown J; Ruiz-Rodriguez C; Owens C; Costello JC; Guo G; Tsang SX; Li Y; Zhou Q; Cai Z; Moore LE; Lucia MS; Dean M; Theodorescu D
Clin Cancer Res; 2014 Sep; 20(18):4935-48. PubMed ID: 25225064
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.
Scott SN; Ostrovnaya I; Lin CM; Bouvier N; Bochner BH; Iyer G; Solit D; Berger MF; Lin O
Cancer Cytopathol; 2017 Jun; 125(6):416-426. PubMed ID: 28339163
[TBL] [Abstract][Full Text] [Related]
3. Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
Hurst CD; Alder O; Platt FM; Droop A; Stead LF; Burns JE; Burghel GJ; Jain S; Klimczak LJ; Lindsay H; Roulson JA; Taylor CF; Thygesen H; Cameron AJ; Ridley AJ; Mott HR; Gordenin DA; Knowles MA
Cancer Cell; 2017 Nov; 32(5):701-715.e7. PubMed ID: 29136510
[TBL] [Abstract][Full Text] [Related]
4. KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer.
Qiu H; Makarov V; Bolzenius JK; Halstead A; Parker Y; Wang A; Iyer GV; Wise H; Kim D; Thayaparan V; Lindner DJ; Haber GP; Ting AH; Ren B; Chan TA; Arora V; Solit DB; Lee BH
Cancer Res; 2023 Mar; 83(6):814-829. PubMed ID: 36638328
[TBL] [Abstract][Full Text] [Related]
5. Activating Telomerase
Zvereva M; Pisarev E; Hosen I; Kisil O; Matskeplishvili S; Kubareva E; Kamalov D; Tivtikyan A; Manel A; Vian E; Kamalov A; Ecke T; Calvez-Kelm FL
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839402
[TBL] [Abstract][Full Text] [Related]
6. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.
Wang L; Zhao Z; Ozark PA; Fantini D; Marshall SA; Rendleman EJ; Cozzolino KA; Louis N; He X; Morgan MA; Takahashi YH; Collings CK; Smith ER; Ntziachristos P; Savas JN; Zou L; Hashizume R; Meeks JJ; Shilatifard A
Nat Med; 2018 Jun; 24(6):758-769. PubMed ID: 29785026
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive integrative profiling of upper tract urothelial carcinomas.
Su X; Lu X; Bazai SK; Compérat E; Mouawad R; Yao H; Rouprêt M; Spano JP; Khayat D; Davidson I; Tannir NN; Yan F; Malouf GG
Genome Biol; 2021 Jan; 22(1):7. PubMed ID: 33397444
[TBL] [Abstract][Full Text] [Related]
8. Inherited KDM6A
Feng M; Chai C; Hao X; Lai X; Luo Y; Zhang H; Tang W; Gao N; Pan G; Liu X; Wang Y; Xiong W; Wu Q; Wang J
Oncogene; 2024 Jun; 43(23):1757-1768. PubMed ID: 38622203
[TBL] [Abstract][Full Text] [Related]
9. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
Al-Ahmadie HA; Iyer G; Lee BH; Scott SN; Mehra R; Bagrodia A; Jordan EJ; Gao SP; Ramirez R; Cha EK; Desai NB; Zabor EC; Ostrovnaya I; Gopalan A; Chen YB; Fine SW; Tickoo SK; Gandhi A; Hreiki J; Viale A; Arcila ME; Dalbagni G; Rosenberg JE; Bochner BH; Bajorin DF; Berger MF; Reuter VE; Taylor BS; Solit DB
Nat Genet; 2016 Apr; 48(4):356-8. PubMed ID: 26901067
[TBL] [Abstract][Full Text] [Related]
10. Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer.
Shobab L; Zheng H; Jensen K; Mendonca-Torres MC; McCoy M; Hoperia V; Rosen J; Wartofsky L; Burman K; Vasko V
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610938
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival.
Yap KL; Kiyotani K; Tamura K; Antic T; Jang M; Montoya M; Campanile A; Yew PY; Ganshert C; Fujioka T; Steinberg GD; O'Donnell PH; Nakamura Y
Clin Cancer Res; 2014 Dec; 20(24):6605-17. PubMed ID: 25316812
[TBL] [Abstract][Full Text] [Related]
12. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia.
Van der Meulen J; Sanghvi V; Mavrakis K; Durinck K; Fang F; Matthijssens F; Rondou P; Rosen M; Pieters T; Vandenberghe P; Delabesse E; Lammens T; De Moerloose B; Menten B; Van Roy N; Verhasselt B; Poppe B; Benoit Y; Taghon T; Melnick AM; Speleman F; Wendel HG; Van Vlierberghe P
Blood; 2015 Jan; 125(1):13-21. PubMed ID: 25320243
[TBL] [Abstract][Full Text] [Related]
13. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
Ler LD; Ghosh S; Chai X; Thike AA; Heng HL; Siew EY; Dey S; Koh LK; Lim JQ; Lim WK; Myint SS; Loh JL; Ong P; Sam XX; Huang D; Lim T; Tan PH; Nagarajan S; Cheng CW; Ho H; Ng LG; Yuen J; Lin PH; Chuang CK; Chang YH; Weng WH; Rozen SG; Tan P; Creasy CL; Pang ST; McCabe MT; Poon SL; Teh BT
Sci Transl Med; 2017 Feb; 9(378):. PubMed ID: 28228601
[TBL] [Abstract][Full Text] [Related]
14. Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Borah S; Xi L; Zaug AJ; Powell NM; Dancik GM; Cohen SB; Costello JC; Theodorescu D; Cech TR
Science; 2015 Feb; 347(6225):1006-10. PubMed ID: 25722414
[TBL] [Abstract][Full Text] [Related]
15. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.
Fu YP; Kohaar I; Moore LE; Lenz P; Figueroa JD; Tang W; Porter-Gill P; Chatterjee N; Scott-Johnson A; Garcia-Closas M; Muchmore B; Baris D; Paquin A; Ylaya K; Schwenn M; Apolo AB; Karagas MR; Tarway M; Johnson A; Mumy A; Schned A; Guedez L; Jones MA; Kida M; Hosain GM; Malats N; Kogevinas M; Tardon A; Serra C; Carrato A; Garcia-Closas R; Lloreta J; Wu X; Purdue M; Andriole GL; Grubb RL; Black A; Landi MT; Caporaso NE; Vineis P; Siddiq A; Bueno-de-Mesquita HB; Trichopoulos D; Ljungberg B; Severi G; Weiderpass E; Krogh V; Dorronsoro M; Travis RC; Tjønneland A; Brennan P; Chang-Claude J; Riboli E; Prescott J; Chen C; De Vivo I; Govannucci E; Hunter D; Kraft P; Lindstrom S; Gapstur SM; Jacobs EJ; Diver WR; Albanes D; Weinstein SJ; Virtamo J; Kooperberg C; Hohensee C; Rodabough RJ; Cortessis VK; Conti DV; Gago-Dominguez M; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Haiman CA; Cussenot O; Cancel-Tassin G; Roupret M; Comperat E; Porru S; Carta A; Pavanello S; Arici C; Mastrangelo G; Grossman HB; Wang Z; Deng X; Chung CC; Hutchinson A; Burdette L; Wheeler W; Fraumeni J; Chanock SJ; Hewitt SM; Silverman DT; Rothman N; Prokunina-Olsson L
Cancer Res; 2014 Oct; 74(20):5808-18. PubMed ID: 25320178
[TBL] [Abstract][Full Text] [Related]
16. Whole genomes redefine the mutational landscape of pancreatic cancer.
Waddell N; Pajic M; Patch AM; Chang DK; Kassahn KS; Bailey P; Johns AL; Miller D; Nones K; Quek K; Quinn MC; Robertson AJ; Fadlullah MZ; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Wilson PJ; Markham E; Cloonan N; Anderson MJ; Fink JL; Holmes O; Kazakoff SH; Leonard C; Newell F; Poudel B; Song S; Taylor D; Waddell N; Wood S; Xu Q; Wu J; Pinese M; Cowley MJ; Lee HC; Jones MD; Nagrial AM; Humphris J; Chantrill LA; Chin V; Steinmann AM; Mawson A; Humphrey ES; Colvin EK; Chou A; Scarlett CJ; Pinho AV; Giry-Laterriere M; Rooman I; Samra JS; Kench JG; Pettitt JA; Merrett ND; Toon C; Epari K; Nguyen NQ; Barbour A; Zeps N; Jamieson NB; Graham JS; Niclou SP; Bjerkvig R; Grützmann R; Aust D; Hruban RH; Maitra A; Iacobuzio-Donahue CA; Wolfgang CL; Morgan RA; Lawlor RT; Corbo V; Bassi C; Falconi M; Zamboni G; Tortora G; Tempero MA; ; Gill AJ; Eshleman JR; Pilarsky C; Scarpa A; Musgrove EA; Pearson JV; Biankin AV; Grimmond SM
Nature; 2015 Feb; 518(7540):495-501. PubMed ID: 25719666
[TBL] [Abstract][Full Text] [Related]
17. Bladder Cancer and Genetic Mutations.
Zhang X; Zhang Y
Cell Biochem Biophys; 2015 Sep; 73(1):65-9. PubMed ID: 27352265
[TBL] [Abstract][Full Text] [Related]
18. Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer.
Ward DG; Baxter L; Gordon NS; Ott S; Savage RS; Beggs AD; James JD; Lickiss J; Green S; Wallis Y; Wei W; James ND; Zeegers MP; Cheng KK; Mathews GM; Patel P; Griffiths M; Bryan RT
PLoS One; 2016; 11(2):e0149756. PubMed ID: 26901314
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
[TBL] [Abstract][Full Text] [Related]
20. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.
Kurtova AV; Xiao J; Mo Q; Pazhanisamy S; Krasnow R; Lerner SP; Chen F; Roh TT; Lay E; Ho PL; Chan KS
Nature; 2015 Jan; 517(7533):209-13. PubMed ID: 25470039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
